Skip to search formSkip to main contentSkip to account menu

Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine

Known as: DTP, Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine DTP 
A vaccine containing detoxified tetanus toxoid, detoxified diphtheria toxoid and inactivated pertussis antigens.
National Institutes of Health

Related topics

Related topics

3 relations
Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine AdsorbedPolyvalent Vaccine

Broader (1)

Diphtheria-Tetanus-Pertussis Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
MicroRNA expression profiles for the NCI-60 cancer cell panel
Advances in the understanding of cancer cell biology and response to drug treatment have benefited from new molecular… 
Review
2005
Review
2005
Patient reminder and recall systems to improve immunization rates
Background: Immunization rates for children and adults are rising, but coverage levels have not reached optimal goals. As a… 
Highly Cited
2004
Highly Cited
2004
Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association
Objective. After concerns about the possible toxicity of thimerosal-containing vaccines in the United States, this study was… 
Highly Cited
1998
Highly Cited
1998
A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine
Background. The goal of the trial was to determine the efficacy of a multicomponent acellular pertussis vaccine against… 
Highly Cited
1998
Highly Cited
1998
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Highly Cited
1998
Highly Cited
1998
Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants
Objective. To determine the safety and immunogenicity of heptavalent pneumococcal saccharide vaccine (serotypes 4, 6B, 9V, 14… 
Highly Cited
1995
Highly Cited
1995
A placebo-controlled trial of a pertussis-toxoid vaccine.
BACKGROUND Although many whole-cell vaccines have been effective in preventing pertussis, these vaccines are difficult to… 
Highly Cited
1995
Highly Cited
1995
The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria…
OBJECTIVE To evaluate the effect of maternally derived antibody on the immunogenicity and reactogenicity of acellular (DTaP) or… 
Review
1990
Review
1990
Polysaccharide-protein conjugates: a new generation of vaccines.
Contributions to science and to the practice of medicine are built on the shoulders of our predecessors. For us, the shoulders of… 
Highly Cited
1981
Highly Cited
1981
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.
In 784 DT and 15,752 DTP immunizations given to children 0 to 6 years of age who were prospectively studied for reactions… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)